The FDA has received reports of adverse events associated with compounded semaglutide products, including dosing errors, contamination, and products containing incorrect ingredients
Semaglutide Biosimilar and Generic Market Size, Share and Trends Analysis Distribution by Product Type (Semaglutide Injectable Generic (Subcutaneous), Semaglutide Oral Tablet Generic, Semaglutide Biosimilar (Biologic Pathway), Semaglutide Peptide API (Merchant Supply), Co-Formulated and Fixed-Dose Combination Generics), By Dosage Form (Disposable Multi-Dose Prefilled Pen, Single-Use Prefilled Autoinjector, Multi-Dose Vials, Single-Dose Vials, Prefilled Cartridges for Reusable Pens, Oral Tablets (Immediate Release)), By Dose Strength (Subcutaneous Injection, Oral Tablet) and Segment Forecasts, 2026 to 2035
Lunch is a kosher hot dog mixed with mayonnaise and a side of egg yolk, rotisserie turkey, and a scoop of mayonnaise
Many of the patients who received vials of compounded semaglutide lacked experience with self-injections, according to the adverse event reports
